Francesco Angelucci Selected Research

Nerve Growth Factors (Neurotrophins)

1/2017	Prolyl isomerase Pin1 and neurotrophins: a loop that may determine the fate of cells in cancer and neurodegeneration.
10/2015	BDNF concentration and impulsiveness level in post-traumatic stress disorder.
8/2014	The effect of neuropeptide Y on cell survival and neurotrophin expression in in-vitro models of Alzheimer's disease.
2/2014	BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure.
4/2013	NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection?
8/2011	BDNF concentrations are decreased in serum and parietal cortex in immunotoxin 192 IgG-Saporin rat model of cholinergic degeneration.
1/2011	Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production.
7/2010	Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms.
1/2010	Facioscapulohumeral muscular dystrophy: do neurotrophins play a role?
1/2009	Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Angelucci Research Topics

Disease

16	Alzheimer Disease (Alzheimer's Disease) 03/2020 - 01/2009
11	Schistosomiasis (Bilharziasis) 01/2021 - 09/2003
8	Neoplasms (Cancer) 01/2022 - 07/2015
7	Schizophrenia (Dementia Praecox) 12/2011 - 01/2004
5	Parasitic Diseases (Parasitic Disease) 01/2020 - 10/2004
5	Cognitive Dysfunction 01/2020 - 02/2010
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 05/2012
5	Neuroblastoma 12/2014 - 01/2011
4	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2011
4	Parkinson Disease (Parkinson's Disease) 04/2016 - 12/2010
4	Psychotic Disorders (Schizoaffective Disorder) 07/2010 - 11/2007
4	Multiple Sclerosis 01/2006 - 05/2004
3	Mental Disorders (Mental Disorder) 10/2016 - 01/2009
3	Chronic Progressive Multiple Sclerosis 01/2006 - 11/2005
2	Infections 12/2021 - 01/2020
2	Inflammation (Inflammations) 06/2021 - 05/2012
2	Epilepsy (Aura) 05/2021 - 01/2021
2	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2018
2	Disease Progression 01/2020 - 01/2019
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 01/2015
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2015 - 02/2014
2	Wounds and Injuries (Trauma) 10/2015 - 02/2014
2	Relapsing-Remitting Multiple Sclerosis 12/2007 - 01/2005
1	Onchocerciasis 01/2022
1	Filariasis 01/2022
1	Filarial Elephantiasis (Lymphatic Filariasis) 01/2022
1	Syndactyly (Polysyndactyly) 01/2022
1	Colitis 06/2021
1	Dysbiosis 05/2021
1	Neglected Diseases 01/2021
1	Glioma (Gliomas) 01/2021
1	Atrophy 01/2020
1	Neuroinflammatory Diseases 05/2019
1	Ulcer 01/2019
1	Hereditary Sensory and Autonomic Neuropathies (HSAN) 01/2019

Drug/Important Bio-Agent (IBA)

24	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 01/2004
14	Nerve Growth Factors (Neurotrophins)IBA 01/2017 - 01/2004
10	Pharmaceutical PreparationsIBA 01/2022 - 09/2008
9	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2005
8	Nerve Growth Factor (NGF)IBA 08/2014 - 03/2000
5	SaporinsIBA 01/2021 - 07/2015
5	Praziquantel (Biltricide)FDA Link 01/2020 - 08/2007
5	Peptides (Polypeptides)IBA 01/2018 - 11/2005
5	CytokinesIBA 05/2012 - 05/2004
4	Amyloid beta-PeptidesIBA 05/2019 - 04/2013
4	Neuroprotective AgentsIBA 10/2014 - 01/2011
4	Olanzapine (Zyprexa)FDA Link 12/2011 - 01/2004
3	Oxidoreductases (Dehydrogenase)IBA 12/2021 - 01/2018
3	EnzymesIBA 01/2021 - 07/2010
3	thioredoxin glutathione reductaseIBA 01/2020 - 10/2010
3	Glutamic Acid (Glutamate)FDA Link 12/2014 - 07/2013
3	Neuropeptide YIBA 08/2014 - 01/2011
3	Amyloid (Amyloid Fibrils)IBA 08/2014 - 01/2011
3	NeuropeptidesIBA 04/2013 - 09/2007
3	Antipsychotic Agents (Antipsychotics)IBA 12/2011 - 01/2004
3	LeptinIBA 12/2007 - 05/2004
2	Thioredoxin-Disulfide ReductaseIBA 01/2022 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 07/2015
2	Phosphotransferases (Kinase)IBA 01/2022 - 11/2017
2	Selenoproteins (Selenoprotein)IBA 01/2022 - 01/2020
2	Sulfhydryl Compounds (Thiols)IBA 01/2021 - 08/2007
2	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2019
2	NucleolinIBA 01/2021 - 01/2018
2	AntibodiesIBA 01/2018 - 01/2005
2	Immunotoxins (Immunotoxin)IBA 01/2018 - 07/2015
2	Biomarkers (Surrogate Marker)IBA 11/2017 - 01/2015
2	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2017 - 08/2007
2	AntigensIBA 07/2015 - 01/2005
2	Messenger RNA (mRNA)IBA 10/2014 - 01/2011
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 12/2011 - 12/2007
2	Antidepressive Agents (Antidepressants)IBA 01/2011 - 12/2010
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2009 - 01/2004
2	Interferon-betaIBA 01/2006 - 11/2005
2	VaccinesIBA 10/2004 - 09/2003
1	FlavoproteinsIBA 12/2021
1	polygalacturonic acid (pectic acid)IBA 12/2021
1	acadesineIBA 06/2021
1	AMP-Activated Protein KinasesIBA 06/2021
1	2,4-dinitrofluorobenzene sulfonic acidIBA 06/2021
1	2,4-dinitrobenzenesulfonic acidIBA 06/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 05/2021
1	ThioredoxinsIBA 01/2021
1	selenolIBA 01/2021
1	PolyethyleneimineIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2020
1	ApolipoproteinsIBA 01/2020
1	Cytidine Diphosphate (CDP)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2019
1	Waste Products (Waste Product)IBA 05/2019
1	PlasminogenIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Nonsense Codon (Nonsense Mutation)IBA 01/2019
1	DystoninIBA 01/2019
1	Ribosome Inactivating ProteinsIBA 01/2018
1	Immunoglobulin FragmentsIBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2020 - 01/2006
2	Cognitive Training 11/2015 - 01/2015
1	Drug Therapy (Chemotherapy) 01/2020
1	Surgical Amputation (Amputations) 01/2019